Chaville, France

Marie-Thérèse Simon-Gage-Soufflot



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marie-Thérèse Simon-Gage-Soufflot: Innovator in Liver Regeneration

Introduction

Marie-Thérèse Simon-Gage-Soufflot is a notable inventor based in Chaville, France. He has made significant contributions to the field of liver regeneration through his innovative research and patent. His work focuses on the use of HIP/PAP polypeptide composition for liver regeneration and the prevention of liver failure.

Latest Patents

Simon-Gage-Soufflot holds a patent for a method that utilizes HIP/PAP polypeptide composition to stimulate liver regeneration. This invention is based on experimental findings that demonstrate the mitogenic and anti-apoptotic effects of HIP/PAP on hepatocytes in primary culture. Furthermore, it has been shown that HIP/PAP is effective in vivo during liver failure and regeneration without adverse effects in mammals. The pharmaceutical composition he developed aims to stimulate liver regeneration after both chronic and acute liver failure, comprising an effective amount of a polypeptide with a specific amino acid sequence.

Career Highlights

Throughout his career, Simon-Gage-Soufflot has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université René Descartes. His research has contributed to advancements in medical science, particularly in the area of liver health.

Collaborations

Some of his notable coworkers include Laurence Christa and Christian Brechot. Their collaborative efforts have furthered the understanding and application of liver regeneration techniques.

Conclusion

Marie-Thérèse Simon-Gage-Soufflot's innovative work in liver regeneration exemplifies the impact of scientific research on medical advancements. His contributions continue to influence the field and offer hope for improved treatments for liver-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…